Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sox0407's Profile
Displaying 801-850 of 2184 result(s).
IPIX Innovation Pharmaceuticals Inc
12/12/2017 12:27:13 PM
Securing an european patent is inde (7)
IPIX Innovation Pharmaceuticals Inc
12/12/2017 12:20:35 AM
New investors, the statement "20% o (2)
IPIX Innovation Pharmaceuticals Inc
12/10/2017 9:06:27 PM
Recent Psoriasis Deals 1. Allergan (1)
IPIX Innovation Pharmaceuticals Inc
12/10/2017 9:02:09 PM
Recent IBD Deals 1. Johnson & Johns (1)
IPIX Innovation Pharmaceuticals Inc
12/10/2017 8:59:09 PM
BP's interests in the Big Three "We (2)
IPIX Innovation Pharmaceuticals Inc
12/09/2017 2:08:42 PM
New investors, naked shorting is al (4)
IPIX Innovation Pharmaceuticals Inc
12/09/2017 12:15:46 AM
New investors, the statement "45% o (3)
IPIX Innovation Pharmaceuticals Inc
12/08/2017 4:30:03 PM
Evidence as in official FINRA or SE (4)
IPIX Innovation Pharmaceuticals Inc
12/08/2017 12:52:51 PM
I respectfully disagree it’s a fa
IPIX Innovation Pharmaceuticals Inc
12/08/2017 12:33:34 PM
I did focus on B-OM. I spent one ho
IPIX Innovation Pharmaceuticals Inc
12/08/2017 12:40:29 AM
Because “silence implies consentâ (3)
IPIX Innovation Pharmaceuticals Inc
12/08/2017 12:34:05 AM
Kelt, you’re welcome to post any (1)
IPIX Innovation Pharmaceuticals Inc
12/08/2017 12:22:08 AM
Kelt, my sole purpose is to get mor (1)
IPIX Innovation Pharmaceuticals Inc
12/07/2017 8:39:44 PM
New investors, the statement "42% o (3)
IPIX Innovation Pharmaceuticals Inc
12/07/2017 2:50:26 PM
I think Leo was trying to find cong
IPIX Innovation Pharmaceuticals Inc
12/07/2017 2:05:10 PM
B-OM sounds like a good candidate f
IPIX Innovation Pharmaceuticals Inc
12/06/2017 11:33:15 PM
Leo’s email to Cabel on K’s the (1)
IPIX Innovation Pharmaceuticals Inc
12/06/2017 11:23:10 PM
Since I haven’t gotten a source (
IPIX Innovation Pharmaceuticals Inc
12/06/2017 8:54:24 PM
Kelt, I still get one response per
IPIX Innovation Pharmaceuticals Inc
12/06/2017 8:25:20 PM
New investors, the statement "35% o (2)
IPIX Innovation Pharmaceuticals Inc
12/06/2017 6:13:35 PM
This week’s trading could be expl (1)
IPIX Innovation Pharmaceuticals Inc
12/06/2017 6:05:09 PM
Here’s a LOL moment. Someone told (3)
IPIX Innovation Pharmaceuticals Inc
12/06/2017 12:00:01 AM
New investors, FINRA didn't say "48 (3)
IPIX Innovation Pharmaceuticals Inc
12/03/2017 12:05:16 PM
New investors, FINRA didn't say "48 (3)
IPIX Innovation Pharmaceuticals Inc
11/28/2017 7:24:47 PM
New investors, FINRA didn't say "61 (4)
IPIX Innovation Pharmaceuticals Inc
11/27/2017 5:53:17 PM
New investors, FINRA didn't say "42 (2)
IPIX Innovation Pharmaceuticals Inc
11/27/2017 5:40:01 PM
Kelt, hope your wife has a speedy r
IPIX Innovation Pharmaceuticals Inc
11/27/2017 1:06:27 AM
Well said. I think this is the week (1)
IPIX Innovation Pharmaceuticals Inc
11/27/2017 12:43:08 AM
Desperate people tend to talk nonse
IPIX Innovation Pharmaceuticals Inc
11/27/2017 12:36:49 AM
There’s no shame in losing to the
IPIX Innovation Pharmaceuticals Inc
11/27/2017 12:29:16 AM
Do you have any source explaining w
IPIX Innovation Pharmaceuticals Inc
11/26/2017 10:27:52 PM
B-OM Due Diligence Lastest Update 1 (3)
IPIX Innovation Pharmaceuticals Inc
11/25/2017 9:40:05 PM
Don’t forget Leo’s legal adviso
IPIX Innovation Pharmaceuticals Inc
11/25/2017 9:14:37 PM
Perhaps I should be more clear. I m
IPIX Innovation Pharmaceuticals Inc
11/25/2017 7:34:42 PM
BP's interests in the Big Three "We (4)
IPIX Innovation Pharmaceuticals Inc
11/25/2017 7:29:32 PM
Recent Psoriasis Deals 1. Allergan (2)
IPIX Innovation Pharmaceuticals Inc
11/25/2017 7:23:52 PM
Recent IBD Deals 1. Johnson & Johns (1)
IPIX Innovation Pharmaceuticals Inc
11/24/2017 8:55:16 PM
New investors, FINRA didn't say "30 (3)
IPIX Innovation Pharmaceuticals Inc
11/23/2017 9:56:12 PM
“Every battle is won BEFORE it is (1)
IPIX Innovation Pharmaceuticals Inc
11/23/2017 3:45:39 AM
Before I say deal or no deal, can I (2)
IPIX Innovation Pharmaceuticals Inc
11/22/2017 10:10:29 PM
I meant even though I don't agree w
IPIX Innovation Pharmaceuticals Inc
11/22/2017 9:50:58 PM
Respectfully, I didn't give up when
IPIX Innovation Pharmaceuticals Inc
11/22/2017 9:46:22 PM
Those #s can't possibly attract new (4)
IPIX Innovation Pharmaceuticals Inc
11/22/2017 9:22:29 PM
Those of you who believe Alan is us (7)
IPIX Innovation Pharmaceuticals Inc
11/22/2017 8:53:34 PM
This post is in response to post 39
IPIX Innovation Pharmaceuticals Inc
11/22/2017 8:40:10 PM
Looks like the whole article was ba
IPIX Innovation Pharmaceuticals Inc
11/22/2017 8:11:29 PM
The AMBS example suggests otherwise (1)
IPIX Innovation Pharmaceuticals Inc
11/22/2017 7:49:58 PM
New investors, FINRA didn't say "40 (2)
IPIX Innovation Pharmaceuticals Inc
11/22/2017 2:53:42 PM
Fair enough, thank you! The article
IPIX Innovation Pharmaceuticals Inc
11/22/2017 2:19:08 PM
I agree many times that naked short (1)
Go to page:
  • << First
  • < Previous
  • 16
  • 17
  • Next >

Recent Articles

  • Anticipating Earnings Outcomes for Usio: What to Expect
  • Latest Developments: Petrus Resources' August Dividend Announcement
  • Investing Insights: Analyzing Xperi's Upcoming Earnings Report
  • Parkland Corporation Achieves Record Second Quarter Results
  • Chorus Aviation Reports Strong Q2 2025 Financial Performance
  • Kneat.com, Inc. Celebrates Record Financial Growth in 2025
  • Clover Health Reports Q2 Growth Amid Stock Price Drop
  • Arista Networks Shows Strong Q2 Growth and Promising Future
  • OR Royalties Announces Q3 2025 Dividend for Shareholders
  • BellRing Brands Under Scrutiny: Investors Urged to Act Now
  • MDA Space Secures Contracts for Advancing Canadian Navy Operations
  • Martinrea International Prepares Q2 Financial Results Call
  • Upstart Holdings Inc. Faces Post-Earnings Stock Decline
  • Petrus Resources Announces Monthly Dividend for Shareholders
  • Diversified Royalty Corp. Declares Cash Dividend and Earnings Date
  • Festival Celebrates Community with Food and Support Services
  • Understanding CSX Inc's P/E Ratio and Market Trends
  • Kneat Reports Significant Year-Over-Year Revenue Growth
  • Allison Transmission Revolutionizes Student Transport in Brazil
  • CT REIT Holds Steady Amid Strong Q2 Operational Success
  • Hyster-Yale Reports Mixed Financial Outcomes for Q2 2025
  • Almadex Expands Exploration Horizons with Red Antler Project
  • Snap Inc's Financial Performance Sparks User Growth Insights
  • GenAI Updates on Annual Financial Statements and Compliance
  • Champion Swimmers Katie Ledecky and Bobby Finke Excel at Championships
  • Lundin Gold Delivers Impressive Results in New Exploration
  • Icahn Enterprises L.P. Sets New Standard with Senior Notes Offering
  • Sucro Limited Consolidates Sweet Life Services Ownership
  • Monthly Dividend Announcement from Pearl Diver Credit Company
  • Innospec's Second Quarter 2025 Highlights and Growth Strategies
  • Exploring Safety in Consumer Products: Canada vs. Poland
  • Fuel Tech's Q2 Results Reflect Growth Potential with FTEK
  • MDA Space Secures Key Contracts to Boost Naval Operations
  • Tigé Boats Revolutionizes Watercraft with 2026 Innovations
  • GenAI Updates on Annual Financial Statements and Future Developments
  • UN Urged to Investigate Ongoing Violence Against Indigenous Women
  • Parkland Corporation's Robust Q2 2025 Performance and Future Outlook
  • Investors Stand Together for Novo Nordisk A/S Class Action
  • Barrick Mining Enhances Transparency with TSF Disclosures
  • Martinrea International Inc. Scheduled to Release Q2 Results
  • Firm Capital Property Trust Announces Strong Second Quarter Results
  • Canoe EIT Income Fund Announces Monthly and Quarterly Distributions
  • Midland States Bancorp Announces Increased Dividend Payouts
  • Fuel Tech Posts Q2 2025 Outcomes Amid Strategic Growth Plans
  • OR Royalties Announces Generous Dividend for Shareholders
  • JELD-WEN Achieves Second Quarter Success Amid Market Challenges
  • Aimee Remey Takes on Investor Relations Role at Inspired Gaming
  • Canoe EIT Income Fund Confirms August Monthly and Quarterly Dividends
  • Opendoor's Q2 Results: Promising Revenue but Challenging Guidance
  • Centrus Energy's Financial Report: Solid Growth and Future Prospects
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site